BMRA
Price
$1.50Alerts
Change
+$0.02 (+1.35%)
Updated
Nov 11 closing price
Capitalization
7.34M
Intraday BUY SELL Signals
ZJYL
Price
$4.91Alerts
Change
+$0.70 (+16.63%)
Updated
Nov 11 closing price
Capitalization
247.51M
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRA vs ZJYL

BMRA vs ZJYL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BMRA vs. ZJYL commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a Hold and ZJYL is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BMRA with price predictions
Nov 11, 2026

BMRA's Stochastic Oscillator is sitting in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The 50-day moving average for BMRA moved above the 200-day moving average on October 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMRA advanced for three days, in 181 of 236 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

BMRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BMRA turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 38 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BMRA moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMRA crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for BMRA entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.214) is normal, around the industry mean (4.142). P/E Ratio (-0.994) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.578) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. BMRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ZJYL with price predictions
Nov 11, 2026

Momentum Indicator for ZJYL turns positive, indicating new upward trend

ZJYL saw its Momentum Indicator move above the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned positive. In 68 of the 75 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ZJYL just turned positive on October 30, 2026. Looking at past instances where ZJYL's MACD turned positive, the stock continued to rise in 26 of 29 cases over the following month. The odds of a continued upward trend are 90%.

ZJYL moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ZJYL crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.

Following a +24.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZJYL advanced for three days, in 162 of 188 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZJYL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

ZJYL broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ZJYL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.351) is normal, around the industry mean (4.964). ZJYL's P/E Ratio (336.000) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.750) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZJYL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
BMRA: Fundamental Ratings
BMRA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRAZJYL
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BMRA: $1.50 vs. ZJYL: $4.91)
Brand notoriety: BMRA and ZJYL are both not notable
BMRA represents the Medical/Nursing Services, while ZJYL is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BMRA: 27% vs. ZJYL: 174%
Market capitalization -- BMRA: $7.34M vs. ZJYL: $247.51M
BMRA [@Medical/Nursing Services] is valued at $7.34M. ZJYL’s [@Pharmaceuticals: Other] market capitalization is $247.51M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 0 FA rating(s) are green while ZJYL’s FA Score has 1 green FA rating(s).

  • BMRA’s FA Score: 0 green, 5 red.
  • ZJYL’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMRA and ZJYL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 5 TA indicator(s) are bullish while ZJYL’s TA Score has 5 bullish TA indicator(s).

  • BMRA’s TA Score: 5 bullish, 5 bearish.
  • ZJYL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZJYL is a better buy in the short-term than BMRA.

Price Growth

BMRA (@Medical/Nursing Services) experienced а -10.18% price change this week, while ZJYL (@Pharmaceuticals: Other) price change was +58.90% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+2.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
Interact to see
Advertisement

BMRA and

Correlation & Price change

A.I.dvisor tells us that BMRA and TRIB have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMRA and TRIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
+1.35%
TRIB - BMRA
33%
Poorly correlated
-2.42%
NVCR - BMRA
28%
Poorly correlated
+1.52%
LFWD - BMRA
26%
Poorly correlated
-1.38%
NNOX - BMRA
26%
Poorly correlated
-2.52%
ESTA - BMRA
25%
Poorly correlated
+5.15%
More

ZJYL and

Correlation & Price change

A.I.dvisor tells us that ZJYL and CLPT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZJYL and CLPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZJYL
1D Price
Change %
ZJYL100%
+16.63%
CLPT - ZJYL
25%
Poorly correlated
+4.56%
BMRA - ZJYL
24%
Poorly correlated
+1.35%
XTNT - ZJYL
22%
Poorly correlated
+1.09%
TELA - ZJYL
21%
Poorly correlated
+17.72%
ICUI - ZJYL
21%
Poorly correlated
-2.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INHD2.800.29
+11.55%
Inno Holdings Inc.
FIGS23.401.01
+4.51%
FIGS
LEN86.33-0.33
-0.38%
Lennar Corp
AURA7.61-0.04
-0.52%
Aura Biosciences
CITR2.42-0.02
-1.02%
CitroTech Inc.